---
layout: post
title: "Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases-Questions and Answers (Revision 1); Draft Guidance for Industry; Availability"
date: 2026-02-05 18:59:15 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-11117
original_published: 2022-05-24 00:00:00 +0000
significance: 8.00
---

# Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases-Questions and Answers (Revision 1); Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** May 24, 2022 00:00 UTC
**Document Number:** 2022-11117

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases--Questions and Answers (Revision 1)." The purpose of this draft guidance is to assist sponsors in the clinical development of new antibacterial drugs, and it provides updates to the options for development programs, given the availability of some new therapeutic options. This draft guidance will provide necessary updates to the final guidance entitled "Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases" published on August 2, 2017.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/05/24/2022-11117/antibacterial-therapies-for-patients-with-an-unmet-medical-need-for-the-treatment-of-serious)
- API: https://www.federalregister.gov/api/v1/documents/2022-11117

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
